Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi.
about
A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in UgandaImplications of mortality transition for primary health care in rural South Africa: a population-based surveillance studyThe development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemicInnovations in health and demographic surveillance systems to establish the causal impacts of HIV policiesHIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care?Control of (multi)drug resistance and tuberculosis incidence over 23 years in the context of a well-supported tuberculosis programme in rural MalawiHypertension and diabetes in Africa: design and implementation of a large population-based study of burden and risk factors in rural and urban MalawiThe unfolding counter-transition in rural South Africa: mortality and cause of death, 1994-2009Maternal mortality in Malawi, 1977-2012Profile: the Karonga Health and Demographic Surveillance SystemThe impact of HIV, an antiretroviral programme and tuberculosis on mortality in South African platinum miners, 1992-2010Estimation and Short-Term Prediction of the Course of the HIV Epidemic Using Demographic and Health Survey Methodology-Like DataParticipation dynamics in population-based longitudinal HIV surveillance in rural South AfricaTrends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level--a comparative analysis of data from four settings in Southern and East Africa.Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaborationUsing health surveillance systems data to assess the impact of AIDS and antiretroviral treatment on adult morbidity and mortality in Botswana.Mortality trends in the era of antiretroviral therapy: evidence from the Network for Analysing Longitudinal Population based HIV/AIDS data on Africa (ALPHA).Data Resource Profile: Network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA Network).Changing predictors of mortality over time from cART start: implications for care.Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funeralsChanging clinical needs of people living with AIDS and receiving home based care in Malawi--the Bangwe Home Based Care Project 2003-2008--a descriptive studyChild mortality in rural Malawi: HIV closes the survival gap between the socio-economic strata.Clinical Improvement by Switching to an Integrase Strand Transfer Inhibitor in Hemophiliac Patients with HIV: The Japan Cohort Study of HIV Patients Infected through Blood ProductsThe promise of record linkage for assessing the uptake of health services in resource constrained settings: a pilot study from South AfricaPopulation-level reduction in adult mortality after extension of free anti-retroviral therapy provision into rural areas in northern Malawi.Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South AfricaExamining the promise of HIV elimination by 'test and treat' in hyperendemic settings.Evidence for localised HIV related micro-epidemics associated with the decentralised provision of antiretroviral treatment in rural South Africa: a spatio-temporal analysis of changing mortality patterns (2007-2010).Methods and baseline results of a repeated cross-sectional survey to assess the public health impact of antiretroviral therapy in Lusaka, ZambiaModeling the cost-effectiveness of HIV treatment: how to buy the most 'health' when resources are limited.Prioritising prevention strategies for patients in antiretroviral treatment programmes in resource-limited settings.Long-term costs and health impact of continued global fund support for antiretroviral therapyIs there an association between PEPFAR funding and improvement in national health indicators in Africa? A retrospective studyPatterns, trends and sex differences in HIV/AIDS reported mortality in Latin American countries: 1996-2007Health impact of external funding for HIV, tuberculosis and malaria: systematic review.Optimal starting point for antiretroviral HIV treatment in a town in Cameroon: a randomised controlled studyOptimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.Combining qualitative and quantitative evidence to determine factors leading to late presentation for antiretroviral therapy in Malawi.How HIV treatment could result in effective prevention
P2860
Q21559730-4206917C-6432-4EC6-A280-47DE3203B891Q24645600-1DFEA902-1544-4DA3-9BEA-95972872BB5CQ24655011-7068CEC1-B8C9-4108-AD36-DF395AFC065CQ26786887-A54BD87B-DCAC-446C-B6F8-AD99C82B1EA5Q27010874-BA450D1B-AB16-49FB-96BB-BB549F62AE9DQ28487692-173C6D12-CFD3-4B1F-873F-CC71CAC8BA40Q28601593-F8637C43-8DB2-450D-93CB-5100D93240D4Q28657739-232CAA02-4BD8-4360-AC4D-78E6D50CFA45Q28660811-23ED2CA5-F113-4100-8B99-F693B8678326Q28727176-8793EDDA-1EF1-455F-8AAE-D8E8F7C690E7Q28728096-873B1FE0-8169-46DE-A91D-054F3FBD3084Q30000083-BBD01F17-C00C-494F-8A11-C2A13A9F52B3Q30373717-67782FDF-382C-4E2B-B09D-4860BAE17B0DQ30388278-671BA087-072C-4F27-A524-5C2E27B70665Q30560890-FB99C2C6-AEFA-4430-8BD7-996AA9A1C43FQ30583563-6E3BEB5C-CEB9-4063-A8AF-2062EA5D5CDBQ30835570-AFE1C1A2-8D24-4ABC-8DDB-D15F095B62D9Q30870461-0B140786-2E49-4D2F-9B41-CE1CD50F1598Q31057094-E183B286-446D-47BB-B9EC-A7C68C4E98D9Q33564975-8A31BC44-2ADF-4D5F-A025-CE5D7B7CBBF7Q33573384-68709211-70BB-4198-8FC9-A70EB6245978Q33615378-0D5D59C3-BB8C-45EA-B198-BDC81BCEADCBQ33623692-5118007E-2A4B-4BB4-8172-B99E822BC9F2Q33668385-811E1249-09F7-4A8F-B47C-F125C1B516DAQ33698153-470BE2A2-26AB-434F-AA1A-D7D455425109Q33728235-703F9787-52AC-48AA-8446-6BD7DA1D6AC3Q33747742-FB7DEDD9-423D-4FFD-B477-B9DFA80BB709Q33780939-EAD6E5E9-0EC2-4F89-85A5-95661F727F64Q33814174-666E22E7-F4AD-4D97-B7EE-378E768D87CAQ33817536-1B920EF8-2E2D-4E5D-ABC5-4B56679C7B99Q33854542-FD5E9283-D251-4130-A5F1-E32217BB37DCQ33926747-3C8F9DD8-76DB-4990-967A-39E2C56D1CC6Q33952153-43D5A4EC-8808-43FB-B4A9-2AB99AFD0F41Q33955129-2D5790F8-F9BE-40E5-9CFD-054B65382B98Q33975593-276DAD37-4C89-4AC7-9FF4-2E6E2E72EB50Q34012430-AE4DE475-448C-4037-AC18-F568DBE476DAQ34067516-62689844-8973-40D6-A16A-955B38D43B79Q34081339-9BB93077-EAF4-4F0A-9E88-0D2E5E03CD03Q34082969-C319507A-03FF-4551-A10C-28C5716EF588Q34090397-9FE4DA7F-9EDD-48BB-97B9-51D2D4EAF04C
P2860
Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Population-level effect of HIV ...... iretroviral therapy in Malawi.
@ast
Population-level effect of HIV ...... iretroviral therapy in Malawi.
@en
type
label
Population-level effect of HIV ...... iretroviral therapy in Malawi.
@ast
Population-level effect of HIV ...... iretroviral therapy in Malawi.
@en
prefLabel
Population-level effect of HIV ...... iretroviral therapy in Malawi.
@ast
Population-level effect of HIV ...... iretroviral therapy in Malawi.
@en
P2093
P2860
P50
P1433
P1476
Population-level effect of HIV ...... iretroviral therapy in Malawi.
@en
P2093
Andreas Jahn
Bernard Mangongo
Fipson Munthali
Frank Mwaungulu
Hazzie Mvula
Johnbosco Mwafilaso
Judith R Glynn
Paul E M Fine
Sian Floyd
Venance Mwinuka
P2860
P304
P356
10.1016/S0140-6736(08)60693-5
P407
P577
2008-05-01T00:00:00Z